NEW YORK (GenomeWeb News) – Saladax Biomedical today said that Lab21 will offer the firm's Personalized Chemotherapy Management assays as a service offering in the UK, Ireland, and Middle East, under a distribution agreement between the firms.

Bethlehem, Pa.-based Saladax said that Lab21 is the first clinical reference lab to offer testing services based on the firm's 5-fluorouracil PCM reagent kits. Cambridge, UK-based Lab21 will market the dose-management service under the trade name DoseCheck.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.